Our Blog

Effect of Probiotics and Prebiotics on Immune Response to Influenza Vaccination in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

We conducted a meta-analysis to evaluate the effects of probiotics and prebiotics on the immune response to influenza vaccination in adults.

Probiotics, Prebiotics, and Synbiotics

According to the German definition, probiotics are defined viable microorganisms, sufficient amounts of which reach the intestine in an active state and thus exert positive health effects.

Baker’s Yeast Beta Glucan Supplementation Increases Salivary IgA and Decreases Cold/Flu Symptomatic Days After Intense Exercise

Strenuous exercise, such as running a marathon, is known to suppress mucosal immunity for up to 24 hr, which can increase the risk of developing an upper respiratory tract infection (URTI)

Baker’s Yeast Beta-Glucan Supplement Reduces Upper Respiratory Symptoms and Improves Mood State in Stressed Women

Several studies have shown a baker’s yeast beta-1,3/1,6-d-glucan, extracted from Saccharomyces cerevisiae, is effective in reducing the incidence of cold and flu symptoms.

Enhancing Immunity in Viral Infections, With Special Emphasis on COVID-19: A Review

Balanced nutrition which can help in maintaining immunity is essential for prevention and management of viral infections.

Zinc and Respiratory Tract Infections: Perspectives for COVID-19 (Review)

Zinc is known to modulate antiviral and antibacterial immunity and regulate inflammatory response.

Prevention and Treatment of Influenza, Influenza-Like Illness, and Common Cold by Herbal, Complementary, and Natural Therapies

There is scientific evidence regarding the effectiveness of several complementary therapies for colds.

The Role of Zinc in Antiviral Immunity

This review focuses on the role of zinc as an essential micronutrient that is required to mount an effective antiviral response.

Does Zinc Supplementation Enhance the Clinical Efficacy of Chloroquine/Hydroxychloroquine to Win Today’s Battle Against COVID-19?

Currently, drug repurposing is an alternative to novel drug development for the treatment of COVID-19 patients.

Improving the Efficacy of Chloroquine and Hydroxychloroquine Against SARS-CoV-2 May Require Zinc Additives – A Better Synergy for Future COVID-19 Clinical Trials

As of now, there is no known effective pharmaceutical agent against the SARS-CoV-2 virus. Read more about the several precautionary measures.